Coronary Microvascular Disease (CMD) Registry

Coronary Microvascular Dysfunction Clinical Trial

Official title:

Coronary Microvascular Disease (CMD) Registry

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05960474
• Other study ID #: STUDY00004429
• Status: Recruiting
• Start date: February 1, 2023
• Est. completion date: January 2033

Study information

• Verified date: May 2023
• Source: Medstar Health Research Institute
• Contact: Megan Rowland
• Phone: 202-877-2959
• Email: megan.e.rowland[@]medstar.net
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of a database of patients with coronary microvascular disease (CMD). This protocol will outline the process for identification and capture of data, storage, as well as data use and sharing internally and externally for research purposes.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: January 2033
• Est. primary completion date: January 2033
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Those with Coronary Microvascular Disease

Related Conditions & MeSH terms

• Coronary Microvascular Dysfunction
• Microvascular Angina

Intervention

Other:
• Outcomes for Patients with CMD
Our objective is to perform a retrospective/prospective descriptive study on the short term to longterm (up to 5 years of follow-up) outcomes of patients with coronary microvascular disease diagnosis invasively

Locations

Country	Name	City	State
United States	Medstar Washington Hospital Center	Washington	District of Columbia

Sponsors (1)

Lead Sponsor	Collaborator
Medstar Health Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Establish a Registry of CMD patients		10 years